Cardiovascular abnormalities in obstructive cholestasis: The possible mechanisms

Liver International

Volumn 33, Issue 1, 2013, Pages 7-15

  Moezi, Leila ^a   Dehpour, Ahmad R ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Abnormalities; Bile acids; Cardiovascular; Cholestasis; Endocannabinoids; Endogenous opioids; Nitric oxide; Obstructive

Indexed keywords

AMINOGUANIDINE; ANANDAMIDE; ATRIAL NATRIURETIC FACTOR; BILE ACID; CATALASE; CIRAZOLINE; ENDOCANNABINOID; ENDORPHIN; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NALTREXONE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TAUROGLYCOCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID;

BLOOD VESSEL REACTIVITY; BRADYCARDIA; CARDIOVASCULAR MALFORMATION; CHOLESTASIS; CONJUGATION; DISEASE ASSOCIATION; HEART FUNCTION; HEMORRHAGIC SHOCK; HUMAN; HYDROPHILICITY; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FAILURE; LIPID PEROXIDATION; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIMARY BILIARY CIRRHOSIS; QT PROLONGATION; REVIEW; VAGUS NERVE STIMULATION; VASODILATATION;

ANIMALS; BILE ACIDS AND SALTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTASIS; ENDOCANNABINOIDS; HUMANS; NITRIC OXIDE; OPIOID PEPTIDES; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM; VASODILATION;

EID: 84870840308     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02803.x     Document Type: Review

References (80)

1. Dawson JL. Acute post-operative renal failure in obstructive jaundice. Ann R Coll Surg Engl 1968; 42: 163-81.
2. Zollinger RM, Williams RD. Surgical aspects of jaundice. Surgery 1956; 39: 1016-30.
3. Williams RD, Elliott DW, Zollinger RM. The effect of hypotension in obstructive jaundice. Arch Surg 1960; 81: 334-40.
4. King JH, Stewart HA. Effect of the injection of bile on the circulation. J Exp Med 1909; 11: 673-85.
5. Green J, Better OS. Systemic hypotension and renal failure in obstructive jaundice-mechanistic and therapeutic aspects. J Am Soc Nephrol 1995; 5: 1853-71.
6. Bomzon A, Rosenberg M, Gali D, et al. Systemic hypotension and decreased pressor response in dogs with chronic bile duct ligation. Hepatology 1986; 6: 595-600.
7. Bomzon A, Weinbroum A, Kamenetz L. Systemic hypotension and pressor responsiveness in cholestasis. A study in conscious 3-day bile duct ligated rats. J Hepatol 1990; 11: 70-6.
8. Tajuddin M, Tariq M, Bilgrami NL, Kumar S. Biochemical and pathological changes in the heart following bile duct ligation. Adv Myocardiol 1980; 2: 209-12.
9. Finberg JP, Syrop HA, Better OS. Blunted pressor response to angiotensin and sympathomimetic amines in bile-duct ligated dogs. Clin Sci (Lond) 1981; 61: 535-9.
10. Binah O, Bomzon A, Blendis LM, Mordohovich D, Better OS. Obstructive jaundice blunts myocardial contractile response to isoprenaline in the dog: a clue to the susceptibility of jaundiced patients to shock? Clin Sci (Lond) 1985; 69: 647-53.
11. Shafaroodi H, Ebrahimi F, Moezi L, et al. Cholestasis induces apoptosis in mice cardiac cells: the possible role of nitric oxide and oxidative stress. Liver Int 2010; 30: 898-905.
12. Cruz A, Tasset I, Ramirez LM, et al. Effect of melatonin on myocardial oxidative stress induced by experimental obstructive jaundice. Rev Esp Enferm Dig 2009; 101: 460-3.
13. Kemp R, Castro-E-Silva O, Santos JS, et al. Evaluation of the mitochondrial respiration of cardiac myocytes in rats submitted to mechanical bile duct obstruction. Acta Cir Bras 2008; 23Suppl. 1: 66-71.
14. Radominska A, Treat S, Little J. Bile acid metabolism and the pathophysiology of cholestasis. Semin Liver Dis 1993; 13: 219-34.
15. Loynes JS, Gowdey CW. Cardiotonic activity of certain steroids and bile salts. Can J Med Sci 1952; 30: 325-32.
16. Joubert P. Cholic acid and the heart: in vitro studies of the effect on heart rate and myocardial contractility in the rat. Clin Exp Pharmacol Physiol 1978; 5: 9-16.
17. Joubert P. An in vivo investigation of the negative chronotropic effect of cholic acid in the rat. Clin Exp Pharmacol Physiol 1978; 5: 1-8.
18. Bogin E, Better O, Harari I. The effect of jaundiced sera and bile salts on cultured beating rat heart cells. Experientia 1983; 39: 1307-8.
19. Dave M, Prabhu S, Arora S, Sanyal RK. Some cardiovascular actions of sodium tauroglycocholate. Indian J Physiol Pharmacol 1974; 18: 93-6.
20. Binah O, Rubinstein I, Bomzon A, Better OS. Effects of bile acids on ventricular muscle contraction and electrophysiological properties: studies in rat papillary muscle and isolated ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 1987; 335: 160-5.
21. Schoenfield LJ, Lachin JM. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety. Ann Intern Med 1981; 95: 257-82.
22. Gazawi H, Ljubuncic P, Cogan U, et al. The effects of bile acids on beta-adrenoceptors, fluidity, and the extent of lipid peroxidation in rat cardiac membranes. Biochem Pharmacol 2000; 59: 1623-8.
23. Seki T, Hagiwara H, Naruse K, et al. In situ identification of messenger RNA of endothelial type nitric oxide synthase in rat cardiac myocytes. Biochem Biophys Res Commun 1996; 218: 601-5.
24. Smith TW, Balligand JL, Kaye DM, et al. The role of the NO pathway in the control of cardiac function. J Card Fail 1996; 4Suppl.: S141-7.
25. Heinemann A, Stauber RE. The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats. Eur J Pharmacol 1995; 278: 87-90.
26. Inan M, Sayek I, Tel BC, Sahin-Erdemli I. Role of endotoxin and nitric oxide in the pathogenesis of renal failure in obstructive jaundice. Br J Surg 1997; 84: 943-7.
27. Mani AR, Nahavandi A, Moosavi M, Safarinejad R, Dehpour AR. Dual nitric oxide mechanisms of cholestasis-induced bradycardia in the rat. Clin Exp Pharmacol Physiol 2002; 29: 905-8.
28. Nahavandi A, Dehpour AR, Mani AR, et al. The role of nitric oxide in bradycardia of rats with obstructive cholestasis. Eur J Pharmacol 2001; 2: 135-41.
29. Gaskari SA, Mani AR, Ejtemaei-Mehr S, et al. Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis? Fundam Clin Pharmacol 2002; 16: 273-9.
30. Ebrahimi F, Tavakoli S, Hajrasouliha AR, et al. Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats. Eur J Pharmacol 2005; 3: 93-100.
31. Hajrasouliha AR, Tavakoli S, Jabehdar-Maralani P, et al. Resistance of cholestatic rats against epinephrine-induced arrhythmia: the role of nitric oxide and endogenous opioids. Eur J Pharmacol 2004; 499: 307-13.
32. Tavakoli S, Hajrasouliha AR, Jabehdar-Maralani P, et al. Modulated hemodynamic response to clonidine in bile duct-ligated rats: the role of nitric oxide. Eur J Pharmacol 2006; 3: 148-53.
33. Dehpour AR, Rastegar H, Jorjani M, et al. Subsensitivity to opioids is receptor-specific in isolated guinea pig ileum and mouse vas deferens after obstructive cholestasis. J Pharmacol Exp Ther 2000; 293: 946-51.
34. Mani AR, Rasool R, Montagnese S, Dehpour AR. Endogenous opioids and liver disease. Scand J Gastroenterol 2006; 41: 1-11.
35. Bergasa NV, Talbot TL, Alling DW, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992; 102: 544-9.
36. Swain MG, Rothman RB, Xu H, et al. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology 1992; 103: 630-5.
37. Jones EA, Bergasa NV. The pruritus of cholestasis: from bile acids to opiate agonists. Hepatology 1990; 11: 884-7.
38. Bergasa NV, Alling DW, Talbot TL, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med 1995; 123: 161-7.
39. Dehpour AR, Akbarloo N, Ghafourifar P. Endogenous nitric oxide modulates naloxone-precipitated withdrawal signs in a mouse model with acute cholestasis. Behav Pharmacol 1998; 9: 77-80.
40. Dehpour AR, Mani AR, Amanlou M, et al. Naloxone is protective against indomethacin-induced gastric damage in cholestatic rats. J Gastroenterol 1999; 34: 178-81.
41. Canossa M, Ventura C, Vaona I, et al. Prodynorphin mRNA expression in adult cultured rat ventricular cardiac myocytes. Biochim Biophys Acta 1993; 1172: 247-50.
42. Springhorn JP, Claycomb WC. Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem J 1989; 258: 73-8.
43. Wong TM, Shan J. Modulation of sympathetic actions on the heart by opioid receptor stimulation. J Biomed Sci 2001; 8: 299-306.
44. Xia Q, Sheng JZ, Tai KK, Wong TM. Effects of chronic U50, 488H treatment on binding and mechanical responses of the rat hearts. J Pharmacol Exp Ther 1994; 268: 930-4.
45. Mantelli L, Amerini S, Rubino A, Ledda F. Characterization of opioid receptors modulating the function of capsaicin-sensitive neurons in guinea-pig atria. Eur J Pharmacol 1990; 3: 325-30.
46. Yu XC, Wang HX, Zhang WM, Wong TM. Cross-talk between cardiac kappa-opioid and beta-adrenergic receptors in developing hypertensive rats. J Mol Cell Cardiol 1999; 31: 597-605.
47. Yu XC, Wang HX, Pei JM, Wong TM. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway. J Mol Cell Cardiol 1999; 31: 1809-19.
48. Shan J, Yu XC, Fung ML, Wong TM. Attenuated "cross talk" between kappa-opioid receptors and beta-adrenoceptors in the heart of chronically hypoxic rats. Pflugers Arch 2002; 2: 126-32.
49. Hajrasouliha AR, Tavakoli S, Jabehdar-Maralani P, et al. Cholestatic liver disease modulates susceptibility to ischemia/reperfusion-induced arrhythmia, but not necrosis and hemodynamic instability: the role of endogenous opioid peptides. J Hepatol 2005; 43: 491-8.
50. Pereira JA, Torregrosa MA, Martinez-Rodenas F, et al. Increased cardiac endocrine activity after common bile duct ligation in the rabbit. Atrial endocrine cells in obstructive jaundice. Ann Surg 1994; 219: 73-8.
51. Yang YY, Liu H, Nam SW, Kunos G, Lee SS. Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids. J Hepatol 2010; 53: 298-306.
52. Meakin J. Jaundice and blood pressure. Med Clin North Am 1932; 16: 715-29.
53. Shasha SM, Better OS, Chaimovitz C, Doman J, Kishon Y. Haemodynamic studies in dogs with chronic bile-duct ligation. Clin Sci Mol Med 1976; 50: 533-7.
54. Raaschou F, Trautner K. Obstruction of the common bile duct in experimental renal hypertension in dogs. Scand J Clin Lab Invest 1953; 5: 223-35.
55. Bomzon L, Wilton PB, Mccalden TA. Impaired skeletal muscle vasomotor response to infused noradrenaline in baboons with obstructive jaundice. Clin Sci Mol Med 1978; 55: 109-12.
56. Bomzon LKM. Renal blood flow in obstructive Jaundice: The baboon as an experimental model. In: Epstein M, ed. The Kidney in Liver Disease. New York: Elsevier, 1978: 167-83.
57. Bomzon A, Ljubuncic P. Bile acids as endogenous vasodilators? Biochem Pharmacol 1995; 49: 581-9.
58. Bomzon A, Finberg JP, Tovbin D, Naidu SG, Better OS. Bile salts, hypotension and obstructive jaundice. Clin Sci (Lond) 1984; 67: 177-83.
59. Pak JM, Adeagbo AS, Triggle CR, Shaffer EA, Lee SS. Mechanism of bile salt vasoactivity: dependence on calcium channels in vascular smooth muscle. Br J Pharmacol 1994; 112: 1209-15.
60. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989; 30: 719-30.
61. Ljubuncic P, Said O, Ehrlich Y, et al. On the in vitro vasoactivity of bile acids. Br J Pharmacol 2000; 131: 387-98.
62. Utkan T, Sarioglu Y, Utkan NZ, Gonullu NN, Yildirim MK. Vascular smooth muscle reactivity and endothelium derived relaxing factor in experimental obstructive jaundice. Arch Physiol Biochem 1996; 104: 30-5.
63. Rastegar H, Jorjani M, Roushanzamir F, et al. Time-dependent reduction of acetylcholine-induced relaxation in aortic rings of cholestatic rats. Pharmacol Res 2001; 44: 519-25.
64. Namiranian K, Samini M, Mehr SE, et al. Mesenteric vascular bed responsiveness in bile duct-ligated rats: roles of opioid and nitric oxide systems. Eur J Pharmacol 2001; 3: 185-93.
65. Atucha N, Iyu D, Ryckerm DE, Soler A, Garcia-Estan J. Altered calcium regulation in freshly isolated aortic smooth muscle cells from bile duct-ligated rats: role of nitric oxide. Cell Calcium 2003; 33: 129-35.
66. Jones EA, Bergasa NV. Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis. Can J Gastroenterol 2000; 14: 33-40.
67. Schadt JC. Sympathetic and hemodynamic adjustments to hemorrhage: a possible role for endogenous opioid peptides. Resuscitation 1989; 3: 219-28.
68. Szabo B, Wichmann T, Starke K. Presynaptic opioid receptors in the portal vein of the rabbit. Eur J Pharmacol 1987; 139: 103-10.
69. Parra L, Perez-Vizcaino F, Alsasua A, Martin MI, Tamargo J. mu-delta-opioid receptor-mediated contractile effects on rat aortic vascular smooth muscle. Eur J Pharmacol 1995; 277: 99-105.
70. Borhani AA, Houshmand G, Samini M, et al. alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide endogenous opioids. Eur J Pharmacol 2005; 3: 183-9.
71. Ebrahimkhani MR, Kiani S, Oakley F, et al. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut 2006; 55: 1606-16.
72. Mani AR, Moore KP. New insights into the role of endogenous opioids in the pathogenesis of gastrointestinal and liver disease. Gut 2009; 58: 893-5.
73. Lee SS, Hadengue A, Moreau R, et al. Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and rats. J Hepatol 1987; 5: 149-53.
74. Wagner JA, Varga K, Jarai Z, Kunos G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 1999; 2: 429-34.
75. Jarai Z, Wagner JA, Varga K, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 1999; 96: 14136-41.
76. Randall MD, Kendall DA. Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol Sci 1998; 19: 55-8.
77. Batkai S, Jarai Z, Wagner JA, et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 2001; 7: 827-32.
78. Ros J, Claria J, To-Figueras J, et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 2002; 122: 85-93.
79. Moezi L, Gaskari SA, Liu H, et al. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors. Br J Pharmacol 2006; 149: 898-908.
80. Moezi L, Rezayat M, Samini M, et al. Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide. Eur J Pharmacol 2004; 486: 53-9.